Contents
-
Surgical Treatments
-
Non-Surgical Approaches
-
Monitoring and Lifestyle Changes
Managing Primary Hyperparathyroidism: What Are Your Options?
Managing Primary Hyperparathyroidism: What Are Your Options?
Why It Matters
Managing primary hyperparathyroidism effectively can prevent serious complications like osteoporosis and kidney stones.
Contents
-
Surgical Treatments
-
Non-Surgical Approaches
-
Monitoring and Lifestyle Changes
Surgical Treatments
Surgery is often the first line of treatment for primary hyperparathyroidism, especially when symptoms are severe. The most common surgery involves removing the overactive parathyroid gland. In some cases, minimally invasive techniques can be used, reducing recovery time and scarring.
Non-Surgical Approaches
For patients who are not candidates for surgery, medication can help manage calcium levels. Drugs like calcimimetics mimic calcium in the bloodstream, helping to reduce PTH secretion. Additionally, bisphosphonates may be prescribed to protect bone health by slowing down bone resorption.
Monitoring and Lifestyle Changes
Regular monitoring of calcium levels is crucial in managing primary hyperparathyroidism. Patients are also encouraged to maintain a balanced diet rich in calcium and vitamin D to support bone health. Staying hydrated and avoiding high-calcium foods can also help manage symptoms.
FAQs
What is the primary treatment for hyperparathyroidism?
Surgery to remove the overactive gland is the most common treatment.
Are there non-surgical treatments?
Yes, medications and lifestyle changes can help manage the condition.
How can lifestyle changes help?
Diet and hydration can manage symptoms and support bone health.
Can primary hyperparathyroidism be cured?
Surgery can often cure the condition by removing the problematic gland.
Key Takeaways
Effective management of primary hyperparathyroidism involves a combination of surgical and non-surgical approaches tailored to the individual.
Additional References
-
Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 1991; 71:371.
-
Sengul Aycicek G, Aydogan BI, Sahin M, et al. Clinical Impact of p27Kip1 and CaSR Expression on Primary Hyperparathyroidism. Endocr Pathol 2018; 29:250.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.